JP2011507946A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507946A5
JP2011507946A5 JP2010540226A JP2010540226A JP2011507946A5 JP 2011507946 A5 JP2011507946 A5 JP 2011507946A5 JP 2010540226 A JP2010540226 A JP 2010540226A JP 2010540226 A JP2010540226 A JP 2010540226A JP 2011507946 A5 JP2011507946 A5 JP 2011507946A5
Authority
JP
Japan
Prior art keywords
nanodispersion
surfactant
salt
docetaxel
paclitaxel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507946A (ja
JP5656643B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2008/000857 external-priority patent/WO2009087678A2/en
Publication of JP2011507946A publication Critical patent/JP2011507946A/ja
Publication of JP2011507946A5 publication Critical patent/JP2011507946A5/ja
Application granted granted Critical
Publication of JP5656643B2 publication Critical patent/JP5656643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540226A 2007-12-24 2008-12-23 ナノ分散体 Active JP5656643B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2527/MUM/2007 2007-12-24
IN2527MU2007 2007-12-24
PCT/IN2008/000857 WO2009087678A2 (en) 2007-12-24 2008-12-23 Nanodispersion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014237028A Division JP5937180B2 (ja) 2007-12-24 2014-11-21 ナノ分散体

Publications (3)

Publication Number Publication Date
JP2011507946A JP2011507946A (ja) 2011-03-10
JP2011507946A5 true JP2011507946A5 (cg-RX-API-DMAC7.html) 2013-11-28
JP5656643B2 JP5656643B2 (ja) 2015-01-21

Family

ID=40853553

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010540226A Active JP5656643B2 (ja) 2007-12-24 2008-12-23 ナノ分散体
JP2014237028A Active JP5937180B2 (ja) 2007-12-24 2014-11-21 ナノ分散体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014237028A Active JP5937180B2 (ja) 2007-12-24 2014-11-21 ナノ分散体

Country Status (20)

Country Link
US (2) US8586062B2 (cg-RX-API-DMAC7.html)
EP (2) EP2853264A1 (cg-RX-API-DMAC7.html)
JP (2) JP5656643B2 (cg-RX-API-DMAC7.html)
KR (1) KR101505419B1 (cg-RX-API-DMAC7.html)
CN (1) CN101909614B (cg-RX-API-DMAC7.html)
AP (1) AP2895A (cg-RX-API-DMAC7.html)
AU (1) AU2008346121B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0821514B8 (cg-RX-API-DMAC7.html)
CA (1) CA2710525C (cg-RX-API-DMAC7.html)
CO (1) CO6290681A2 (cg-RX-API-DMAC7.html)
DK (1) DK2231144T3 (cg-RX-API-DMAC7.html)
EA (1) EA016434B1 (cg-RX-API-DMAC7.html)
ES (1) ES2509490T3 (cg-RX-API-DMAC7.html)
IL (1) IL206584A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010007076A (cg-RX-API-DMAC7.html)
NZ (1) NZ586343A (cg-RX-API-DMAC7.html)
PL (1) PL2231144T3 (cg-RX-API-DMAC7.html)
UA (1) UA100543C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009087678A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201004450B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102802624A (zh) * 2009-06-19 2012-11-28 太阳医药高级研发有限公司 药物的纳米分散体以及它的制备方法
CN102038635A (zh) * 2009-10-23 2011-05-04 天津天士力集团有限公司 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
KR20110056042A (ko) * 2009-11-20 2011-05-26 주식회사유한양행 종양세포 표적지향을 위한 나노 입자 및 이의 제조방법
CA2798180A1 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
CN102078300B (zh) * 2011-01-27 2012-01-11 海南美大制药有限公司 托拉塞米脂质体固体制剂
CN102366409B (zh) * 2011-09-14 2013-03-20 海南灵康制药有限公司 一种尼扎替丁脂质体固体制剂
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US10736327B2 (en) * 2013-03-14 2020-08-11 Griffith Foods International Inc. Natural fungicide composition
US20170099833A1 (en) * 2014-05-30 2017-04-13 Oms Investments, Inc. Nano-sized water-based dispersion compositions and methods of making thereof
KR101692314B1 (ko) * 2015-03-27 2017-01-03 주식회사 주빅 지용성 약물의 생분해성 고분자 내 용해 시스템: 스마트 폴리머 시스템
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
US11304898B2 (en) 2015-06-09 2022-04-19 Sun Pharma Advanced Research Company Ltd Method of treating carcinoma
CN107551390A (zh) * 2017-08-21 2018-01-09 常熟佳禾生物科技有限公司 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法
CA3094162A1 (en) * 2018-03-19 2019-09-26 Epicyt Pharma Ab A composition for use in the treatment of conditions caused by calcium deficiency
US11423574B2 (en) 2019-12-17 2022-08-23 Emma Ruccio Method and apparatus for detecting scoliosis
US11877717B2 (en) 2019-12-17 2024-01-23 Emma Ruccio Method and apparatus for detecting scoliosis
EP3928772B1 (en) * 2020-06-26 2024-06-19 Algiax Pharmaceuticals GmbH Nanoparticulate composition
JP7745863B2 (ja) * 2021-04-12 2025-09-30 国立大学法人広島大学 難水溶性物質の可溶化方法および難水溶性物質の可溶化組成物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018A (en) * 1849-01-09 Improvement in bog-cutters
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US6753006B1 (en) * 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR19990075621A (ko) * 1998-03-23 1999-10-15 임성주 경사 평판형 배양조
US6017948A (en) 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6365191B1 (en) * 1999-02-17 2002-04-02 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
ATE347886T1 (de) 1999-09-23 2007-01-15 Dabur Pharma Ltd Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen
TWI230616B (en) * 2000-09-25 2005-04-11 Ind Tech Res Inst Liposome for incorporating large amounts of hydrophobic substances
US20020192280A1 (en) * 2001-05-01 2002-12-19 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
DE10124952A1 (de) * 2001-05-21 2002-12-12 Bayer Ag Verfahren zur Herstellung von Nanodispersionen
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20050288521A1 (en) * 2004-06-29 2005-12-29 Phytogen Life Sciences Inc. Semi-synthetic conversion of paclitaxel to docetaxel
CA2598441A1 (en) 2005-02-24 2006-08-31 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
CA2611592A1 (en) 2005-06-17 2006-12-21 Hospira Australia Pty Ltd Liquid pharmaceutical formulations of docetaxel
CA2626016A1 (en) * 2005-10-21 2007-06-21 Panacea Biotec Limited Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof

Similar Documents

Publication Publication Date Title
JP2011507946A5 (cg-RX-API-DMAC7.html)
CN108046276B (zh) 一种羧基封端的聚乙二醇修饰的介孔二氧化硅纳米颗粒的制备及其用途
JP2019512006A5 (cg-RX-API-DMAC7.html)
JP2013534981A5 (cg-RX-API-DMAC7.html)
JP2009542795A5 (cg-RX-API-DMAC7.html)
JP2014534294A5 (cg-RX-API-DMAC7.html)
JP2014531456A5 (cg-RX-API-DMAC7.html)
JP2012533408A5 (cg-RX-API-DMAC7.html)
JP2012514682A5 (cg-RX-API-DMAC7.html)
Nguyen et al. Reverse micelles prepared from amphiphilic polylactide-b-poly (ethylene glycol) block copolymers for controlled release of hydrophilic drugs
JP2008517878A5 (cg-RX-API-DMAC7.html)
JP2011219761A5 (cg-RX-API-DMAC7.html)
JP2016523833A5 (cg-RX-API-DMAC7.html)
Ye et al. A pH‐Sensitive Injectable Nanoparticle Composite Hydrogel for Anticancer Drug Delivery
US20090196937A1 (en) Temperature-sensitive nano-carriers
CN101766584B (zh) 聚乙二醇/水溶性壳聚糖协同修饰的长循环可降解聚合物纳米微囊及其制备方法
JP2013528838A5 (cg-RX-API-DMAC7.html)
JP2009074034A5 (cg-RX-API-DMAC7.html)
Ding et al. Conjugated oligoelectrolyte-polyhedral oligomeric silsesquioxane loaded pH-responsive nanoparticles for targeted fluorescence imaging of cancer cell nucleus
JP2015513311A5 (cg-RX-API-DMAC7.html)
JP2008538751A5 (cg-RX-API-DMAC7.html)
Li et al. Facile construction of well-defined fullerene–dendrimer supramolecular nanocomposites for bioapplications
CN110354072B (zh) 一种近红外光响应的氧化石墨烯/凹凸棒石复合超分子水凝胶的制备和应用
JP2014076971A5 (cg-RX-API-DMAC7.html)
JP2011519893A5 (cg-RX-API-DMAC7.html)